{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:59:53Z","timestamp":1793249993378,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UM1DA059000"],"award-info":[{"award-number":["UM1DA059000"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008513","name":"Thomas Jefferson University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jad.2025.119829","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T10:58:18Z","timestamp":1751713098000},"page":"119829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Acute and chronic effects of medicinal cannabis use on anxiety and depression in a prospective cohort of patients new to cannabis"],"prefix":"10.1016","volume":"390","author":[{"given":"David","family":"Wolinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiannon E.","family":"Mayhugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Surujnarain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Thrul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Vandrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.119829_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135594","article-title":"Chronic administration of synthetic cannabidiol induces antidepressant effects involving modulation of serotonin and noradrenaline levels in the hippocampus","volume":"744","author":"Abame","year":"2021","journal-title":"Neurosci Lett."},{"issue":"11","key":"10.1016\/j.jad.2025.119829_bb0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40263-023-01046-z","article-title":"A semi-naturalistic, open-label trial examining the effect of prescribed medical cannabis on neurocognitive performance","volume":"37","author":"Arkell","year":"2023","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.jad.2025.119829_bb0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psychres.2015.09.014","article-title":"Cannabis use and mental health-related quality of life among individuals with depressive disorders","volume":"230","author":"Aspis","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.119829_bb0025","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s11606-020-05800-7","article-title":"Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population","volume":"35","author":"Azcarate","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jad.2025.119829_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2018.05.065","article-title":"Medical and non-medical marijuana use in depression: longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization","volume":"241","author":"Bahorik","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119829_bb0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2018.05.065","article-title":"Medical and non-medical marijuana use in depression: longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization","volume":"241","author":"Bahorik","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119829_bb0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/M23-2811","article-title":"Trends in US medical Cannabis registrations, authorizing clinicians, and reasons for use from 2020 to 2022","volume":"177","author":"Boehnke","year":"2024","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2025.119829_bb0250","series-title":"Suicide data and statistics","author":"Centers for Disease Control and Prevention","year":"2025"},{"issue":"9","key":"10.1016\/j.jad.2025.119829_bb0045","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5","article-title":"Validation of the Edmonton symptom assessment scale","volume":"88","author":"Chang","year":"2000","journal-title":"Cancer: Interdisciplinary International Journal of the American Cancer Society"},{"key":"10.1016\/j.jad.2025.119829_bb0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugalcdep.2017.03.030","article-title":"Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress","volume":"177","author":"Childs","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.jad.2025.119829_bb0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119829_bb0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jad.2018.04.054","article-title":"A naturalistic examination of the perceived effects of cannabis on negative affect","volume":"235","author":"Cuttler","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119829_bb0065","article-title":"Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms in adults: a randomized clinical trial","volume":"5(3):e222106-e","author":"Gilman","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.jad.2025.119829_bb0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/jcp.0b013e31815152a5","article-title":"Selective serotonin reuptake inhibitor discontinuation: side effects and other factors that influence medication adherence","volume":"27","author":"Goethe","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119829_bb0075","article-title":"Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain","volume":"26","author":"Goodell","year":"2021","journal-title":"Internet Interv."},{"issue":"10","key":"10.1016\/j.jad.2025.119829_bb0080","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1007\/s12325-023-02622-x","article-title":"The economic burden of adults with major depressive disorder in the United States (2019)","volume":"40","author":"Greenberg","year":"2023","journal-title":"Adv. Ther."},{"issue":"9","key":"10.1016\/j.jad.2025.119829_bb0085","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2009.06.006","article-title":"The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants","volume":"30","author":"Hill","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.jad.2025.119829_bb0090","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1176\/ps.2009.60.11.1466","article-title":"The STAR* D trial: revealing the need for better treatments","volume":"60","author":"Insel","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2025.119829_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.invent.2024.100784","article-title":"Predictors of participant compliance with ecological momentary assessment among individuals with chronic pain who are using cannabis and opioids","volume":"38","author":"Joo","year":"2024","journal-title":"Internet Interv."},{"issue":"2","key":"10.1016\/j.jad.2025.119829_bb0105","first-page":"251","article-title":"The effectiveness of cannabis flower for immediate relief from symptoms of depression","volume":"93","author":"Li","year":"2020","journal-title":"Yale J. Biol. Med."},{"issue":"1","key":"10.1016\/j.jad.2025.119829_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","volume":"41","author":"Linares","year":"2019","journal-title":"Braz. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2025.119829_bb0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/02698811241229524","article-title":"A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance","volume":"38","author":"Manning","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119829_bb0120","article-title":"Antidepressant and anxiolytic effects of medicinal cannabis use in an observational trial","volume":"12","author":"Martin","year":"2021","journal-title":"Front. Psych."},{"issue":"3","key":"10.1016\/j.jad.2025.119829_bb0125","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2025.119829_bb0130","author":"NCSL"},{"key":"10.1016\/j.jad.2025.119829_bb2130","series-title":"The implications of COVID-19 for mental health and substance use","author":"Panchal","year":"2023"},{"issue":"Pt A","key":"10.1016\/j.jad.2025.119829_bb0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","volume":"76","author":"Patel","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2025.119829_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108626","article-title":"Endocannabinoids, cannabinoids and the regulation of anxiety","volume":"195","author":"Petrie","year":"2021","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.jad.2025.119829_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/070674371506000104","article-title":"The STAR*D trial: it is time to reexamine the clinical beliefs that guide the treatment of major depression","volume":"60","author":"Pigott","year":"2015","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119829_bb0150","first-page":"1","article-title":"Integrating endocannabinoid signalling in depression","author":"Rana","year":"2021","journal-title":"J. Mol. Neurosci."},{"issue":"12","key":"10.1016\/j.jad.2025.119829_bb0155","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2025.119829_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114573","article-title":"Medical cannabis use in Canada and its impact on anxiety and depression: a retrospective study","volume":"313","author":"Sachedina","year":"2022","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.jad.2025.119829_bb0165","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex","volume":"56","author":"Sales","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.jad.2025.119829_bb0170","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1089\/can.2020.0165","article-title":"Clinician beliefs and practices related to cannabis","volume":"7","author":"Schauer","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.jad.2025.119829_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107969","article-title":"Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis","volume":"211","author":"Schlienz","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.jad.2025.119829_bb0180","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1089\/can.2019.0096","article-title":"A cross-sectional and prospective comparison of medicinal cannabis users and controls on self-reported health","volume":"6","author":"Schlienz","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"issue":"13","key":"10.1016\/j.jad.2025.119829_bb0185","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1017\/S0033291717003658","article-title":"Developmental sensitivity to cannabis use patterns and risk for major depressive disorder in mid-life: findings from 40 years of follow-up","volume":"48","author":"Schoeler","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2025.119829_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02518-2","article-title":"Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties","volume":"18","author":"Sharpe","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jad.2025.119829_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.clinpsy.3.022806.091415","article-title":"Ecological momentary assessment","volume":"4","author":"Shiffman","year":"2008","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.jad.2025.119829_bb0200","article-title":"Acute effects of smoked and vaporized Cannabis in healthy adults who infrequently use Cannabis: a crossover trial","volume":"1(7):e184841. Epub 20181102","author":"Spindle","year":"2018","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.jad.2025.119829_bb0205","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/02698811211021583","article-title":"Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis","volume":"35","author":"Spindle","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2025.119829_bb0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.119829_bb0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jat\/bkx012","article-title":"Pharmacokinetic profile of oral cannabis in humans: blood and oral fluid disposition and relation to pharmacodynamic outcomes","volume":"41","author":"Vandrey","year":"2017","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.jad.2025.119829_bb0220","article-title":"Excess mortality in depressive and anxiety disorders: the lifelines cohort study","volume":"64","author":"Voshaar","year":"2021","journal-title":"Eur. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2025.119829_bb0225","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1192\/bjp.bp.110.085100","article-title":"Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders","volume":"199","author":"Wahlbeck","year":"2011","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.119829_bb0230","doi-asserted-by":"crossref","first-page":"69","DOI":"10.26828\/cannabis\/2021.02.006","article-title":"Health outcomes among adults initiating medical Cannabis for chronic pain: a 3-month prospective study incorporating ecological momentary assessment (EMA)","volume":"4","author":"Wang","year":"2021","journal-title":"Cannabis"},{"key":"10.1016\/j.jad.2025.119829_bb0235","article-title":"Physical activity and depression and anxiety disorders: a systematic review of reviews and assessment of causality","volume":"2","author":"Wanjau","year":"2023","journal-title":"AJPM Focus"},{"issue":"6","key":"10.1016\/j.jad.2025.119829_bb0240","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"issue":"259","key":"10.1016\/j.jad.2025.119829_bb0245","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front. Pharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725012716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725012716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:02:13Z","timestamp":1779717733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725012716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":49,"alternative-id":["S0165032725012716"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.119829","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute and chronic effects of medicinal cannabis use on anxiety and depression in a prospective cohort of patients new to cannabis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.119829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119829"}}